Literature DB >> 9225835

Is the plasma uridine level a marker of the overproduction of uric acid?

T Yamamoto1, Y Moriwaki, S Takahashi, Z Tsutsumi, J Yamakita, K Higashino.   

Abstract

To determine whether the plasma level of uridine can be used to identify patients with gout, the plasma concentration of uridine was determined in patients with gout and normal subjects. Plasma uridine was significantly higher in patients with gout than in normal subjects. It was also significantly higher in patients with gout of the overexcretion (of uric acid) type than in those with gout of the underexcretion type. Plasma uridine was used to classify gout patients into underexcretion and overexcretion types, with a diagnostic accuracy of 92.5%. Results indicate that the plasma uridine concentration may be a marker of uric acid production and can be used to separate hyperuricemia into the overexcretion and underexcretion types.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9225835     DOI: 10.1016/s0026-0495(97)90126-8

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  3 in total

Review 1.  Pathogenesis of hyperuricemia: recent advances.

Authors:  Manisha Ghei; Mihaela Mihailescu; Dennis Levinson
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

2.  Blood uridine concentration may be an indicator of the degradation of pyrimidine nucleotides during physical exercise with increasing intensity.

Authors:  Wioleta Dudzinska; Anna Lubkowska; Barbara Dolegowska; Krzysztof Safranow
Journal:  J Physiol Biochem       Date:  2010-06-09       Impact factor: 4.158

3.  Metabolites involved in purine degradation, insulin resistance, and fatty acid oxidation are associated with prediction of Gestational diabetes in plasma.

Authors:  Lauren E McMichael; Hannah Heath; Catherine M Johnson; Rob Fanter; Noemi Alarcon; Adilene Quintana-Diaz; Kari Pilolla; Andrew Schaffner; Elissa Jelalian; Rena R Wing; Alex Brito; Suzanne Phelan; Michael R La Frano
Journal:  Metabolomics       Date:  2021-11-27       Impact factor: 4.290

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.